- expand access to needle and syringe programs, particularly in rural/regional areas
- expand eligibility for drug diversion programs
- train and equip police to carry naloxone

Drug Summit report: www.health.nsw.gov.au/aod/summit/D...

Now, just over a year later, CDA Clinics QLD has gone into administration and the case against the company may be dismissed. The medicinal cannabis industry and the Australian community would have been much better off if the TGA had acted faster and more decisively.

Excellent article by Andrew Proudfoot, well worth a read.

🔗Download now to get the full picture of the current state of cannabis in Australia: www.penington.org.au/cannabis-in-...

At the same time, 42.3% of Australians aged 18+ say they have used cannabis, 80% believe using cannabis should not be a criminal offence, net approval for regular cannabis use has continued to increase, and 54% of Victorians support a regulated adult use cannabis access model.

That growth is being driven primarily by access to dried flower products, with the market share of oral liquid products declining from 30% of units sold in 2022 H2, to 15% in 2024 H1.

Australia's medicinal cannabis market is booming - from January to June 2024, over 2.8 million units of prescribed medicinal cannabis were sold to patients, equating to roughly $400m+ in estimated revenue. At the current growth trajectory, annual sales could reach $1b this year.

🔹A significant upsurge in the Australian medicinal cannabis market.
🔹An increase in the number of Australians who say they have used cannabis in their lifetime.
🔹The size of Australia's illicit cannabis market, estimated to be $5 billion a year.